On June 13, 2013, the Supreme Court of the United States unanimously decided that companies cannot patent naturally occurring human genes. This is an interesting distinction as it breaks away from other cases regarding DNA patenting and collecting within the US. Earlier this month, SCOTUS ruled that police agencies could collect and indefinitely store human DNA, even if charges are dropped. This ruling identifies DNA similar to fingerprints in the eyes of the law in forensics information gathering. Also, previously to this ruling, SCOTUS has ruled that companies can patent synthesized genes.

This case has garnered national attention due to some interesting events in popular media. In May actress Angelina Jolie had a double mastectomy. According to the news , after learning that she was extremely likely to develop breast cancer because she was a carrier of the BRCA1 gene. The case before SCOTUS was directly tied into this very BRCA1 gene. Myriad Genetics of Utah, was the only company that had developed a test to identify this gene and had patented the gene to maintain a monopoly over the testing. With this ruling other companies will now be able to develop testing, which should bring down the price of the test and make it available to more people. In time it is speculated that the BRCA1 test will become commonplace and lives will be saved as a direct result of this ruling.

DNA Services of America is pleased with this ruling. While we currently do not offer BRCA1 testing, we know that with this gene now open to further research more and more testing opportunities will become available.

DNA testing and analysis for medical diagnostic and disease predisposition is still a very young field. This ruling by SCOTUS will encourage growth within the field. By safeguarding against patenting naturally occurring genes, companies will be able to develop new studies and tests to identify other diseases and cancers. Hopefully, through this ruling and others like it, medical professionals will be able to provide better care for their patients by having better information with which to make important medical decisions.

If you believe that you are a potential carrier of the BRCA1 gene, or have a family history of breast cancer, we encourage you to contact you family physician and discuss you situation and options.

Monday, June 3rd, with a slim margin of 5 to 4, the Supreme Court of the United States agreed that police can sample DNA from an arrested individual and keep the specimen afterward, regardless of innocence or guilt.  This is one of two cases before the Supreme Court this year as they also tackle the controversial case of whether or not corporations can patent DNA.  Both of these subjects are important and reflect deeply on the nature of privacy and the very building blocks of life that compose a human.

DNA Services of America is a company that tests and profiles DNA sequences for individuals to answer questions for genealogy purposes, paternity disputes, forensic testing, and even immigration services.  As such, this is a very important topic.  So the question is to be asked, do you own the rights to your own DNA and should that be private?

To begin with, it is important to note that the Supreme Court’s ruling only applies to person apprehended.  The police can’t lift DNA without probably cause, currently.  In this regard, the Supreme Court has decided that DNA is similar to a fingerprint and is nothing more than an identifying mark of a person.  Applications of collecting DNA are important for cases of sexual abuse, as well as when blood is present at a crime scene, etc.  The application of this law should help keep people who are innocent from being prosecuted.  The disturbing aspect of the case is the nature that the police can keep a copy of your DNA on file once it is collected.  This is again similar to fingerprints, which are taken during an arrest and then kept on file.  Personally, while it may seem that is a overstep of power for both law enforcement agencies and the Supreme Court, the decision was based off of current practices already in place throughout the United States.

However, the next case to be heard is truly interesting.  Can a company patent genes?  Can a company patent DNA?  While the thought itself seems absurd, there are important questions to be asked that are at the heart of this case, and it goes beyond privacy.  Ultimately the case will be built around the idea that companies are experimenting with DNA and therefore any findings they have that can benefit can be patented and protected.  This begins to sound like something out of a science fiction story, or the movie GATTACA.  However as we move forward in DNA studies these questions will have to be asked and defined.  It is interesting to note that this time is already here.

“I am often asked for information about paternity testing. It is so convenient that you come to the hospital to do the sample collection, and it helps our patients so much. I am so thankful to have a trusted source.” – Donna E., Birth Records Coordinator